Silo Pharma, Inc., a developmental stage biopharmaceutical company focused on combining traditional therapeutics with psychedelic research, announced a new exclusive license agreement with medical technology manufacturer Medspray Pharma BV for its...
Lupin stated that its abbreviated new drug application for Dapagliflozin Tablets has gained preliminary clearance from the US Food and Drug Administration. The medications are prescribed to patients with type 2 diabetes. The company said that the...
With the release of its new guideline on the prevention and management of wasting and nutritional oedema (acute malnutrition), the World Health Organization (WHO) is furthering the worldwide fight against acute malnutrition in children under the...
Torrent Pharma, a Rs. 9,400 crore plus pharma company, reported a robust financial performance in the second quarter ending September 2023, despite decreasing revenues in the United States. Its consolidated net profit climbed by 23.7% to Rs. 386...
Roche announced the debut of the LightCycler PRO System, which is based on the established gold standard technology of previous LightCycler Systems. This innovative technology improves performance and usability while bridging the gap between...
Owl Therapeutics, a fully owned subsidiary of Gryphon Bio, announced a global license and partnership agreement with Lund, Sweden-based Abliva AB to advance Abliva's NeuroSTAT (OWL-1410) for the prevention and treatment of moderate to severe...
The pharmaceutical quality control system is projected to experience significant growth, with the market size expected to increase from USD 1.4 billion in 2022 to USD 4.5 billion by 2032.
A team of three talented B Tech (Computer Engineering) students from NMIMS School of Technology Management and Engineering (STME), Indore, Riyanshi Bariya, Vandita Pathak, and Shalom Ram, have developed a healthcare device, 'Sehat Sathi: A Smart...
The first patient has been randomized in the phase 1 REGENERATE MSA-101 clinical trial of AB-1005, a gene therapy being developed as a treatment for multiple system atrophy-parkinsonian type (MSA-P). Asklepios BioPharmaceutical, Inc. (AskBio)...
Truqap (capivasertib) by AstraZeneca has got the clearance in the United States for the treatment of adult patients with hormone receptor (HR)-positive, HER2-negative locally advanced or metastatic breast cancer with one or more biomarker...
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")